STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

SUSAN G KOMEN BREAST CANCER FOUNDATION: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
SUSAN G KOMEN BREAST CANCER FOUNDATION (EIN 75-1835298)
Tax period
2011-04-01 to 2012-03-31
Filed
2012-11-30
IRS object ID
201233359349300718
Schema version
2011v1.3
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2012-11-30T16:00:51-06:00Timestamp
Tax Period End Date2012-03-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line11901 SIXTH AVE NORTH STE 1200AddressLine1
CityBIRMINGHAMCity
StateALState
ZIP Code35203ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-04-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN751835298EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1SUSAN G KOMEN BREAST CANCER FOUNDATION INCBusinessNameLine1
FieldValueIRS element (for citing)
In Care Of Name% Mark NadolnyInCareOfName
Name ControlSUSANameControl
Phone9728551600Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ FREEWAYAddressLine1
CityDALLASCity
StateTXState
ZIP Code752446125ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameMARK NADOLNYName
TitleCFOTitle
Date Signed2012-11-30DateSigned

Preparer Preparer

FieldValueIRS element (for citing)
Phone2052541608Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

Doing Business As DoingBusinessAs

FieldValueIRS element (for citing)
Business Name Line1SUSAN G KOMEN FOR THE CUREBusinessNameLine1
FieldValueIRS element (for citing)
Name Of Principal Officer PersonAmbassador Nancy G BrinkerNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line15005 LBJ FREEWAY STE 250AddressLine1
CityDALLASCity
StateTXState
ZIP Code752446125ZIPCode
FieldValueIRS element (for citing)
Gross Receipts299790668GrossReceipts
Group Return For AffiliatesfalseGroupReturnForAffiliates
Group Exemption Number7164GroupExemptionNumber
Organization501c3XOrganization501c3
Web Sitewww.komen.orgWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1982YearFormation
State Legal DomicileTXStateLegalDomicile
Activity Or Mission DescriptionOur mission is a world without breast cancer; to save lives by empowering people, ensuring quality care for all, and energizing science to discover and deliver the cures.ActivityOrMissionDescription
Nbr Voting Members Governing Body9NbrVotingMembersGoverningBody
Nbr Independent Voting Members7NbrIndependentVotingMembers
Total Nbr Employees346TotalNbrEmployees
Total Nbr Volunteers9500TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Contributions Grants Prior Year174658160ContributionsGrantsPriorYear
Contributions Grants Current Year159779664ContributionsGrantsCurrentYear
Program Service Revenue Prior Year34417471ProgramServiceRevenuePriorYear
Program Service Revenue CY33193701ProgramServiceRevenueCY
Investment Income Prior Year6372156InvestmentIncomePriorYear
Investment Income Current Year7951630InvestmentIncomeCurrentYear
Other Revenue Prior Year-6491760OtherRevenuePriorYear
Other Revenue Current Year-3836540OtherRevenueCurrentYear
Total Revenue Prior Year208956027TotalRevenuePriorYear
Total Revenue Current Year197088455TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year76205302GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY71697843GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year24232513SalariesEtcPriorYear
Salaries Etc Current Year26312020SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year829211TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY1160108TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year25743361TotalFundrsngExpCurrentYear
Other Expense Prior Year91171573OtherExpensePriorYear
Other Expenses Current Year89188244OtherExpensesCurrentYear
Total Expenses Prior Year192438599TotalExpensesPriorYear
Total Expenses Current Year188358215TotalExpensesCurrentYear
Revenues Less Expenses Prior Year16517428RevenuesLessExpensesPriorYear
Revenues Less Expenses CY8730240RevenuesLessExpensesCY
Total Assets BOY319777847TotalAssetsBOY
Total Assets EOY313104320TotalAssetsEOY
Total Liabilities BOY205749113TotalLiabilitiesBOY
Total Liabilities EOY193001246TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY114028734NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY120103074NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionOur Promise: To save lives and end breast cancer forever by EMPOWERING PEOPLE, ENSURING QUALITY CARE FOR ALL, AND ENERGIZING SCIENCE TO discover and deliver the cures.MissionDescription
Significant New Program ServicesfalseSignificantNewProgramServices
Significant ChangefalseSignificantChange
Expense70833312Expense
Grants60931021Grants
Revenue33926771Revenue
DescriptionGrants to other charitable organizations to support research and clinical investigation of breast cancer. See schedule O for additional details.Description

Activity2 Activity2

FieldValueIRS element (for citing)
Expense71273697Expense
Grants5594191Grants
Revenue0Revenue
DescriptionPublic health education programs to increase the public's AWARENESS of breast cancer including, among other things, detection and treatment. See schedule O for additional details.Description

Activity3 Activity3

FieldValueIRS element (for citing)
Expense9482705Expense
Grants5172631Grants
Revenue0Revenue
DescriptionHealth treatment and screening programs and grants. See schedule O for additional details.Description
FieldValueIRS element (for citing)
Total Of Other Program Service Exp0TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt0TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev0TotalOfOtherProgramServiceRev
Total Program Service Expense151589714TotalProgramServiceExpense
Described In501 C3trueDescribedIn501C3
Schedule B RequiredtrueScheduleBRequired
Political ActivitiesfalsePoliticalActivities
Lobbying ActivitiestrueLobbyingActivities
Subject To Proxy TaxfalseSubjectToProxyTax
Donor Advised FundsfalseDonorAdvisedFunds
Conservation EasementsfalseConservationEasements
Collections Of ArtfalseCollectionsOfArt
Credit CounselingfalseCreditCounseling
Term Or Permanent EndowmentstrueTermOrPermanentEndowments
Report Land Bldg EquiptrueReportLandBldgEquip
Report Invest Oth SecuritiesfalseReportInvestOthSecurities
Report Prog Rel InvestfalseReportProgRelInvest
Report Other AssetsfalseReportOtherAssets
Report Other LiabilitiesfalseReportOtherLiabilities
Report Fin48 FootnotetrueReportFin48Footnote
Independent Audit Financial StmtfalseIndependentAuditFinancialStmt
Consolidated Audit Financial StmttrueConsolidatedAuditFinancialStmt
SchoolfalseSchool
Foreign OfficefalseForeignOffice
Foreign ActivitiestrueForeignActivities
More Than5000 K To OrganizationstrueMoreThan5000KToOrganizations
More Than5000 K To IndividualsfalseMoreThan5000KToIndividuals
Professional FundraisingtrueProfessionalFundraising
Fundraising ActivitiestrueFundraisingActivities
GamingfalseGaming
HospitalfalseHospital
Grants To OrganizationstrueGrantsToOrganizations
Grants To IndividualsfalseGrantsToIndividuals
Schedule J RequiredtrueScheduleJRequired
Tax Exempt BondsfalseTaxExemptBonds
Excess Benefit TransactionfalseExcessBenefitTransaction
Prior Excess Benefit TransactionfalsePriorExcessBenefitTransaction
Loan To Officer Or DQPfalseLoanToOfficerOrDQP
Grant To Related PersonfalseGrantToRelatedPerson
Bsnss Rltnshp With OrganizationfalseBsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family MemberfalseBsnssRltnshpThruFamilyMember
Officer Entity With Bsnss RltnshpfalseOfficerEntityWithBsnssRltnshp
Deductible Non Cash ContributionstrueDeductibleNonCashContributions
Deductible Contributions Of ArtfalseDeductibleContributionsOfArt
TerminatedfalseTerminated
Partial LiquidationfalsePartialLiquidation
Disregarded EntityfalseDisregardedEntity
Related EntityfalseRelatedEntity
Related Org Controlled EntityfalseRelatedOrgControlledEntity
Transaction Related EntityfalseTransactionRelatedEntity
Transfers To Exempt Non Chrtbl OrgfalseTransfersToExemptNonChrtblOrg
Activities Conducted PartnershipfalseActivitiesConductedPartnership
Schedule O RequiredtrueScheduleORequired
Number Forms Transmitted With1096255NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup WitholdingtrueComplianceWithBackupWitholding
Number Of Employees346NumberOfEmployees
Employment Tax Returns FiledtrueEmploymentTaxReturnsFiled
Unrelated Business IncomefalseUnrelatedBusinessIncome
Foreign Financial AccounttrueForeignFinancialAccount
Name Of Foreign CountryISNameOfForeignCountry
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTrans
Taxable Party NotificationfalseTaxablePartyNotification
Non Deductible ContributionsfalseNonDeductibleContributions
Quid Pro Quo ContributionstrueQuidProQuoContributions
Quid Pro Quo DisclosuretrueQuidProQuoDisclosure
Form8282 Property Disposed OffalseForm8282PropertyDisposedOf
Funds To Pay PremiumsfalseFundsToPayPremiums
Premiums PaidfalsePremiumsPaid
Indoor Tanning ServicesfalseIndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members9NbrVotingGoverningBodyMembers
Number Independent Voting Members7NumberIndependentVotingMembers
Family Or Business RelationshiptrueFamilyOrBusinessRelationship
Delegation Of Management DutiesfalseDelegationOfManagementDuties
Changes To Organizing DocsfalseChangesToOrganizingDocs
Material Diversion Or MisusefalseMaterialDiversionOrMisuse
Members Or StockholdersfalseMembersOrStockholders
Election Of Board MembersfalseElectionOfBoardMembers
Decisions Subject To ApprovalfalseDecisionsSubjectToApproval
Minutes Of Governing BodytrueMinutesOfGoverningBody
Minutes Of CommitteestrueMinutesOfCommittees
Officer Mailing AddressfalseOfficerMailingAddress
Local ChapterstrueLocalChapters
Policies Reference ChapterstruePoliciesReferenceChapters
Form990 Provided To Governing BodytrueForm990ProvidedToGoverningBody
Conflict Of Interest PolicytrueConflictOfInterestPolicy
Annual Disclosure Covered PersonstrueAnnualDisclosureCoveredPersons
Regular Monitoring EnforcementtrueRegularMonitoringEnforcement
Whistleblower PolicytrueWhistleblowerPolicy
Document Retention PolicytrueDocumentRetentionPolicy
Compensation Process CEOtrueCompensationProcessCEO
Compensation Process OthertrueCompensationProcessOther
Investment In Joint VenturefalseInvestmentInJointVenture
States Where Copy Of Return Is FiledALStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledAKStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledAZStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledARStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCOStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCTStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledDCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledFLStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledGAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledHIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledILStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledINStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledKSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledKYStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMEStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMDStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMNStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMOStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNHStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNJStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNMStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNYStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNDStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledOHStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledOKStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledORStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledPAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledRIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledSCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledTNStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledUTStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledVAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWVStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWIStatesWhereCopyOfReturnIsFiled
Own WebsiteXOwnWebsite
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

FieldValueIRS element (for citing)
Name PersonMark NadolnyNamePerson
Telephone Number9728551600TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line15005 LBJ FREEWAY SUITE 250AddressLine1
CityDALLASCity
StateTXState
ZIP Code752446125ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (21 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationOfficerOfficerKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
Dr LaSalle D Leffall Jr
Chairman of the BOD(4/11-3/12)1.0X000
Eric Brinker
Board Member (Ending 3/12)1.0X000
Linda Custard
Board Member (on LOA eff 6/11)1.0X000
Brenda Lauderback
Board Member1.0X000
John D Raffaelli
Board Member1.0X000
Linda Law
Board Member & Asst. Secretary1.0X000X
Connie O'Neill
Board Member & Treasurer1.0X000X
Elyse Gellerman
Board Member1.0X000
Jane Abraham
Temp Bd Mbr for L.Custard(6/111.0X000
Nancy G Brinker
Founder, Board Member & CEO55.0X684717011430X
Elizabeth Thompson
President55.0375246016952X
Katrina McGhee
Executive VP, CMO55.0319024012373X
Mark Nadolny
Chief Financial Officer55.0337696021119X
Jonathan Blum
Gen Consl & Sec (ending 10/11)55.0364334020373X
Lesley Lurie
Asst Secretary (Begn 11/11)55.0185427014811X
Eric Winer
Chief Scientific Advisor20.021084200X
Julie Teer
VP, Development55.023037800X
David Dawson
VP, Information Technology55.0220129016220X
Margo Lucero
VP,Business Dev & Partnerships55.0173115021187X
Chandini Portteus
VP, Res, Eval & Scientific prg55.0171204015006X
Nancy Macgregor
VP, Global Networks55.0198814016787X
FieldValueIRS element (for citing)
Total Reportable Comp From Org3470926TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation166258TotalOtherCompensation
Number Individuals GT100 K52NumberIndividualsGT100K
Formers ListedfalseFormersListed
Total Comp GT150 KtrueTotalCompGT150K
Compensation From Other SourcesfalseCompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
Event 360 Inc
205 N Michigan AvenueCHICAGOIL606015927Event Management10901943
Merkle Response Services Inc
PO Box 64897BALTIMOREMD21264DONAT. PROCESS & MKT6243836
Convio Inc
PO Box 671445DALLASTX752671445Donation processing4032972
RADARWORKS
6100 WILSHIRE BOULEVARDLOS ANGELESCA90048MARKETING2747791
ADECCO EMPLOYMENT SERVICES
175 BROADHOLLOW ROADMELVILLENY11747TEMP STAFFING SVCS1958688
FieldValueIRS element (for citing)
Number Of Contractors GT100 K56NumberOfContractorsGT100K
Federated Campaigns316818FederatedCampaigns
Fundraising Events78631238FundraisingEvents
All Other Contributions80831608AllOtherContributions
Noncash Contributions72070NoncashContributions
Total Contributions159779664TotalContributions

Program Service Revenue ProgramServiceRevenue

FieldValueIRS element (for citing)
DescriptionAffiliate PaymentsDescription
Business Code900099BusinessCode
Total Revenue Column33193701TotalRevenueColumn
Related Or Exempt Function Income33193701RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue33193701TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column3813804TotalRevenueColumn
Exclusion$3,813,804ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

FieldValueIRS element (for citing)
Total Revenue Column0TotalRevenueColumn

Royalties Revenue RoyaltiesRevenue

FieldValueIRS element (for citing)
Total Revenue Column714346TotalRevenueColumn
Exclusion$714,346ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities95380157Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities91242331Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities4137826Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column4137826TotalRevenueColumn
Exclusion$4,137,826ExclusionAmount
FieldValueIRS element (for citing)
Gross Income Fundraising Events4976100GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events78631238CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses10638369FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column-5662269TotalRevenueColumn
Exclusion-$5,662,269ExclusionAmount

Net Income From Gaming NetIncomeFromGaming

FieldValueIRS element (for citing)
Total Revenue Column0TotalRevenueColumn
FieldValueIRS element (for citing)
Gross Sales Of Inventory754583GrossSalesOfInventory
Cost Of Goods Sold821513CostOfGoodsSold

Net Income Or Loss NetIncomeOrLoss

FieldValueIRS element (for citing)
Total Revenue Column-66930TotalRevenueColumn
Related Or Exempt Function Income-66930RelatedOrExemptFunctionIncome

Other Revenue Misc OtherRevenueMisc (2 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncomeExclusionExclusionAmount
Support services900099800000800000
Other900099378313$378,313
FieldValueIRS element (for citing)
Total Other Revenue1178313TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column197088455TotalRevenueColumn
Related Or Exempt Function Income33926771RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$3,382,020ExclusionAmount
FieldValueIRS element (for citing)
Info In Schedule O Part IXXInfoInScheduleOPartIX

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total65717515Total
Program Services65717515ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total0Total

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total5980328Total
Program Services5980328ProgramServices

Benefits To Members BenefitsToMembers

FieldValueIRS element (for citing)
Total0Total

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total2477286Total
Program Services2105693ProgramServices
Management And General247729ManagementAndGeneral
Fundraising123864Fundraising

Comp Disqual Persons CompDisqualPersons

FieldValueIRS element (for citing)
Total0Total

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total19786428Total
Program Services13795724ProgramServices
Management And General4107634ManagementAndGeneral
Fundraising1883070Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total656005Total
Program Services445114ProgramServices
Management And General151140ManagementAndGeneral
Fundraising59751Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total2108070Total
Program Services1463039ProgramServices
Management And General446303ManagementAndGeneral
Fundraising198728Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total1284231Total
Program Services896135ProgramServices
Management And General263393ManagementAndGeneral
Fundraising124703Fundraising

Fees For Services Management FeesForServicesManagement

FieldValueIRS element (for citing)
Total0Total

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total270166Total
Program Services195866ProgramServices
Management And General56209ManagementAndGeneral
Fundraising18091Fundraising

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total582329Total
Program Services396810ProgramServices
Management And General121162ManagementAndGeneral
Fundraising64357Fundraising

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total9832Total
Program Services9832ProgramServices

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total1160108Total
Fundraising1160108Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total278468Total
Program Services189754ProgramServices
Management And General57939ManagementAndGeneral
Fundraising30775Fundraising

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total0Total

Advertising Advertising

FieldValueIRS element (for citing)
Total19643947Total
Program Services15068310ProgramServices
Management And General305117ManagementAndGeneral
Fundraising4270520Fundraising

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total13167239Total
Program Services6756535ProgramServices
Management And General225866ManagementAndGeneral
Fundraising6184838Fundraising

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total4011388Total
Program Services3209111ProgramServices
Management And General240683ManagementAndGeneral
Fundraising561594Fundraising

Royalties Royalties

FieldValueIRS element (for citing)
Total0Total

Occupancy Occupancy

FieldValueIRS element (for citing)
Total1967443Total
Program Services1388010ProgramServices
Management And General404720ManagementAndGeneral
Fundraising174713Fundraising

Travel Travel

FieldValueIRS element (for citing)
Total3990342Total
Program Services2969674ProgramServices
Management And General685147ManagementAndGeneral
Fundraising335521Fundraising

Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials

FieldValueIRS element (for citing)
Total0Total

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total1345225Total
Program Services868673ProgramServices
Management And General322872ManagementAndGeneral
Fundraising153680Fundraising

Interest Interest

FieldValueIRS element (for citing)
Total0Total

Payments To Affiliates PaymentsToAffiliates

FieldValueIRS element (for citing)
Total0Total

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total1572358Total
Program Services1158736ProgramServices
Management And General272070ManagementAndGeneral
Fundraising141552Fundraising

Insurance Insurance

FieldValueIRS element (for citing)
Total-33901Total
Program Services-24446ProgramServices
Management And General-6149ManagementAndGeneral
Fundraising-3306Fundraising

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
CONSULTING AND PROF SERVICES209562791697224916593212324709
EQUIP RENTAL AND MAINTENANCE1129218459220377380292618
EVENT PRODUCTION889829368342553905891673449
BANK FEES3519843380892345003104451

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total7879775Total
Program Services4352685ProgramServices
Management And General661515ManagementAndGeneral
Fundraising2865575Fundraising

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total188358215Total
Program Services151589714ProgramServices
Management And General11025140ManagementAndGeneral
Fundraising25743361Fundraising
FieldValueIRS element (for citing)
Joint CostsXJointCosts

Total Joint Costs TotalJointCosts

FieldValueIRS element (for citing)
Total65800029Total
Program Services37451525ProgramServices
Management And General6131267ManagementAndGeneral
Fundraising22217237Fundraising

Cash Non Interest Bearing CashNonInterestBearing

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY50614983BOY
EOY56524309EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY59432769BOY
EOY45091699EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY1923864BOY
EOY1158074EOY

Receivables From Officers Etc ReceivablesFromOfficersEtc

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Receivables From Disqual Persons ReceivablesFromDisqualPersons

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

FieldValueIRS element (for citing)
BOY3861903BOY
EOY4281900EOY

Inventories For Sale Or Use InventoriesForSaleOrUse

FieldValueIRS element (for citing)
BOY638001BOY
EOY508986EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY2039706BOY
EOY2016583EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis12230333LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec9597471LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY3701014BOY
EOY2632862EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY197565607BOY
EOY200889907EOY

Investments Other Securities InvestmentsOtherSecurities

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Investments Program Related InvestmentsProgramRelated

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Intangible Assets IntangibleAssets

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY319777847BOY
EOY313104320EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY32386936BOY
EOY26817905EOY

Grants Payable GrantsPayable

FieldValueIRS element (for citing)
BOY173362177BOY
EOY166183341EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Escrow Account Liability EscrowAccountLiability

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Loans From Officers Directors LoansFromOfficersDirectors

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Unsecured Notes Loans Payable UnsecuredNotesLoansPayable

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY205749113BOY
EOY193001246EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY66987655BOY
EOY78174629EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY46816079BOY
EOY41603445EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY225000BOY
EOY325000EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY114028734BOY
EOY120103074EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY319777847BOY
EOY313104320EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses8730240ReconcilationRevenueExpenses
Reconcilation Other Changes-2655900ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or ReviewfalseAccountantCompileOrReview
FS AuditedtrueFSAudited
Audit CommitteetrueAuditCommittee
Financial Statement ConsolidatedXFinancialStatementConsolidated
Federal Grant Audit RequiredfalseFederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org170b1 AviXPubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years132775607CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years127995868CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years134999587CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year174658160CurrentTaxYearMinus1Year
Current Tax Year159779664CurrentTaxYear
Total730208886Total

Tax Rev Levied For Org Benefit170 TaxRevLeviedForOrgBenefit170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years0CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years0CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years0CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year0CurrentTaxYearMinus1Year
Current Tax Year0CurrentTaxYear
Total0Total

Value Srvc Fclts Furnished By Govt ValueSrvcFcltsFurnishedByGovt

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years0CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years0CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years0CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year0CurrentTaxYearMinus1Year
Current Tax Year0CurrentTaxYear
Total0Total

Total170 Total170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years132775607CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years127995868CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years134999587CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year174658160CurrentTaxYearMinus1Year
Current Tax Year159779664CurrentTaxYear
Total730208886Total
FieldValueIRS element (for citing)
Amounts Subst Contributors Total1749349AmountsSubstContributorsTotal
Public Support Total170728459537PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years8682291CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years6957976CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years3548746CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year3812083CurrentTaxYearMinus1Year
Current Tax Year4528150CurrentTaxYear
Total27529246Total

Net UBI NetUBI

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years0CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years0CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years0CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year0CurrentTaxYearMinus1Year
Current Tax Year0CurrentTaxYear
Total0Total

Other Income170 OtherIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years81914CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years71369CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years2589864CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year84038CurrentTaxYearMinus1Year
Current Tax Year378313CurrentTaxYear
Total3205498Total
FieldValueIRS element (for citing)
Total Support760943630TotalSupport
Gross Receipts From Admissions Etc196229303GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage1700.95731PublicSupportPertcentage170
Public Support Pertcent Prior Year0.93417PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170XThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Org Belongs To Affiliated GroupXOrgBelongsToAffiliatedGroup

Total Grassroots Lobbying TotalGrassrootsLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals
Affiliated Group Totals519831AffiliatedGroupTotals

Total Direct Lobbying TotalDirectLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals9832FilingOrganizationsTotals
Affiliated Group Totals136387AffiliatedGroupTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals9832FilingOrganizationsTotals
Affiliated Group Totals656218AffiliatedGroupTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals177323243FilingOrganizationsTotals
Affiliated Group Totals345691395AffiliatedGroupTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals177333075FilingOrganizationsTotals
Affiliated Group Totals346347613AffiliatedGroupTotals

Lobbying Nontaxable LobbyingNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals1000000FilingOrganizationsTotals
Affiliated Group Totals1000000AffiliatedGroupTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals250000FilingOrganizationsTotals
Affiliated Group Totals250000AffiliatedGroupTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

FieldValueIRS element (for citing)
Affiliated Group Totals269831AffiliatedGroupTotals
FieldValueIRS element (for citing)
Tot Lobby Expend Mns Lobbying NontxTotLobbyExpendMnsLobbyingNontx
Form4720 FiledtrueForm4720Filed

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

FieldValueIRS element (for citing)
Current Year Minus31000000CurrentYearMinus3
Current Year Minus21000000CurrentYearMinus2
Current Year Minus11000000CurrentYearMinus1
Current Year1000000CurrentYear
Total4000000Total
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

FieldValueIRS element (for citing)
Current Year Minus3375201CurrentYearMinus3
Current Year Minus2295135CurrentYearMinus2
Current Year Minus1552301CurrentYearMinus1
Current Year656218CurrentYear
Total1878855Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

FieldValueIRS element (for citing)
Current Year Minus3250000CurrentYearMinus3
Current Year Minus2250000CurrentYearMinus2
Current Year Minus1250000CurrentYearMinus1
Current Year250000CurrentYear
Total1000000Total
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

FieldValueIRS element (for citing)
Current Year Minus3275601CurrentYearMinus3
Current Year Minus2219954CurrentYearMinus2
Current Year Minus1439745CurrentYearMinus1
Current Year519831CurrentYear
Total1455131Total

Form990 Schedule C Part IV Form990ScheduleCPartIV

FieldValueIRS element (for citing)
IdentifierLobbying ExpensesIdentifier
Return ReferenceSchedule C Part II-AReturnReference
ExplanationPublic policy initiatives have the potential to impact people touched by BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM.Explanation

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmtsArtPublicExhibitionAmts
Held Works Of Art AmtsHeldWorksOfArtAmts

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance1225000BeginningOfYearBalance
Contributions100000Contributions
Investment Earnings Or Losses33InvestmentEarningsOrLosses
Grants Or Scholarships0GrantsOrScholarships
Other Expenditures33OtherExpenditures
End Of Year Balance1325000EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance1225000BeginningOfYearBalance
Investment Earnings Or Losses608InvestmentEarningsOrLosses
Grants Or Scholarships0GrantsOrScholarships
Other Expenditures608OtherExpenditures
End Of Year Balance1225000EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

FieldValueIRS element (for citing)
Beginning Of Year Balance1225000BeginningOfYearBalance
Contributions4284Contributions
Investment Earnings Or Losses-4284InvestmentEarningsOrLosses
Grants Or Scholarships0GrantsOrScholarships
Other Expenditures0OtherExpenditures
End Of Year Balance1225000EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

FieldValueIRS element (for citing)
Beginning Of Year Balance1318022BeginningOfYearBalance
Investment Earnings Or Losses5240InvestmentEarningsOrLosses
Grants Or Scholarships98262GrantsOrScholarships
Other Expenditures0OtherExpenditures
End Of Year Balance1225000EndOfYearBalance
FieldValueIRS element (for citing)
Board Designated EOY Balance0.75000BoardDesignatedEOYBalance
Permanent Endowment EOY Balance0.25000PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.00000TermEndowmentEOYBalance
Endowments Held By Unrelated OrgsfalseEndowmentsHeldByUnrelatedOrgs
Endowments Held By Related OrgsfalseEndowmentsHeldByRelatedOrgs
LandLand
BuildingsBuildings

Leasehold Improvements LeaseholdImprovements

FieldValueIRS element (for citing)
Other Cost Or Other Basis795374OtherCostOrOtherBasis
Depreciation563108Depreciation
Book Value232266BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis4100227OtherCostOrOtherBasis
Depreciation3625214Depreciation
Book Value475013BookValue

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis7334732OtherCostOrOtherBasis
Depreciation5409149Depreciation
Book Value1925583BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings2632862TotalOfBookValueLandBuildings
Federal Income Tax Liability0FederalIncomeTaxLiability
Total Of Amounts0TotalOfAmounts

Form990 Schedule D Part XIV Form990ScheduleDPartXIV

FieldValueIRS element (for citing)
IdentifierENDOWMENTSIdentifier
Return ReferenceSchedule D, Part VReturnReference
ExplanationTwo permanent endowments, Goodman-Brinker and Firnberg. Goodman-Brinker Endowment to be used for Breast Cancer Research fellowships. Firnberg Endowment to be used for breast cancer educational programs and research awards. The prior years endowment fund amounts were restated to match the organization's audited financial statements. During Fiscal Year 2012, A third permanent endowment of $100,000 was funded, the earnings of which are restricted for use in the Houston and surrounding counties. FIN 48 (ASC740) Financial Statement Disclosure Schedule D, Part X, Line 2 The Organization is subject to a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. There were no uncertain tax positions recorded in the financial statements at March 31, 2012 and March 31, 2011.Explanation

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedtrueGrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (16 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
Central America and the Caribbean04Program ServicesEduc. & Event Support17921
East Asia and the Pacific01Program ServicesEduc. & Event Support250
Europe (including Iceland and Greenland)02Program ServicesEduc. & Event Support31433
Middle East and North Africa08Program ServicesEduc. & Event Support68277
North America05Program ServicesEduc. & Event Support7519
Russia and the Newly Independent States01Program ServicesEduc. & Event Support7694
Central America and the Caribbean00GrantmakingEducation Grants212465
East Asia and the Pacific00GrantmakingResearch Grants574751
Europe (including Iceland and Greenland)00GrantmakingEducation Grants383058
Europe (including Iceland and Greenland)00GrantmakingResearch Grants1498580
Middle East and North Africa00GrantmakingEducation Grants418980
North America00GrantmakingEducation Grants643163
North America00GrantmakingResearch Grants1551040
South America00GrantmakingEducation Grants408598
South America00GrantmakingResearch Grants160000
Sub-Saharan Africa00GrantmakingEducation Grants129692
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees21SubtotalNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees21TotalNumberOfEmployees
Subtotal Amount Spent6113421SubtotalAmountSpent
Total Amount Spent6113421TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (46 entries)

RegionRegionPurpose Of GrantPurposeOfGrantAmount Of Cash GrantAmountOfCashGrantManner Of Cash DisbursementMannerOfCashDisbursement
Sub-Saharan AfricaEducation50000wire transf
Cent. America/CaribbeanEducation135000wire transf
North AmericaEducation199308wire transf
Europe/Iceland/GreenlandResearch232785wire transf
Middle East/North AfricaEducation123950wire transf
Sub-Saharan AfricaEducation35000wire transf
North AmericaResearch250000wire transf
North AmericaEducation25000wire transf
Europe/Iceland/GreenlandEducation28000wire transf
Europe/Iceland/GreenlandEducation10000wire transf
Europe/Iceland/GreenlandEducation25000wire transf
South AmericaEducation100257wire transf
Europe/Iceland/GreenlandResearch258782wire transf
Cent. America/CaribbeanEducation7500wire transf
South AmericaEducation7500wire transf
Cent. America/CaribbeanEducation69965wire transf
North AmericaEducation218555wire transf
Europe/Iceland/GreenlandEducation25000wire transf
Europe/Iceland/GreenlandResearch91954wire transf
South AmericaResearch160000wire transf
South AmericaEducation49997wire transf
Europe/Iceland/GreenlandResearch125000wire transf
Europe/Iceland/GreenlandEducation94452wire transf
North AmericaResearch154779wire transf
Europe/Iceland/GreenlandResearch140000wire transf
Europe/Iceland/GreenlandResearch196012wire transf
Europe/Iceland/GreenlandResearch122048wire transf
North AmericaResearch779936wire transf
Middle East/North AfricaEducation20000wire transf
Middle East/North AfricaEducation12900wire transf
East Asia/PacificResearch199264wire transf
Europe/Iceland/GreenlandEducation64200wire transf
Sub-Saharan AfricaEducation35000wire transf
South AmericaEducation100844wire transf
North AmericaResearch160000wire transf
Europe/Iceland/GreenlandResearch140000wire transf
Europe/Iceland/GreenlandEducation136406wire transf
South AmericaEducation150000wire transf
Sub-Saharan AfricaEducation9693wire transf
North AmericaResearch161325wire transf
East Asia/PacificResearch335487wire transf
North AmericaEducation200300wire transf
North AmericaResearch45000wire transf
Europe/Iceland/GreenlandResearch192000wire transf
East Asia/PacificResearch40000wire transf
Middle East/North AfricaEducation247130wire transf
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs46TotalNumberOf501c3Orgs
Transfer To Foreign CorpfalseTransferToForeignCorp
Interest In Foreign TrustfalseInterestInForeignTrust
Own Foreign CorpfalseOwnForeignCorp
Passive Foreign Invest CofalsePassiveForeignInvestCo
Foreign PartnershipfalseForeignPartnership
Boycott CountriesfalseBoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierProcedures for monitoring Grant Funds outside of the United StatesIdentifier
Return ReferenceSchedule F, Part VReturnReference
ExplanationAll research, education, screening, and treatment grantees are required to submit annual financial and progress reports and change requests for modifications to their project. All reports and requests are reviewed by science staff. See Schedule I, Part IV for more details.Explanation

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsXMailSolicitations
Email SolicitationsXEmailSolicitations
In Person SolicitationsXInPersonSolicitations
Solicitation Of Non Govt GrantsXSolicitationOfNonGovtGrants
Special Fundraising EventsXSpecialFundraisingEvents
Agreement Ref FundraisingtrueAgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation

FieldValueIRS element (for citing)
Name Of IndividualMerkle IncNameOfIndividual
ActivityDirect MarketingActivity
Fundraiser Control Of FundsfalseFundraiserControlOfFunds
Gross Receipts26416121GrossReceipts
Amount Retained By Contractor1158268AmountRetainedByContractor
Net To Organization25257853NetToOrganization
FieldValueIRS element (for citing)
Total Gross Receipts26416121TotalGrossReceipts
Total Retained By Contractors1158268TotalRetainedByContractors
Total Net To Organization25257853TotalNetToOrganization
Licensed StatesALLicensedStates
Licensed StatesAKLicensedStates
Licensed StatesAZLicensedStates
Licensed StatesARLicensedStates
Licensed StatesCALicensedStates
Licensed StatesCOLicensedStates
Licensed StatesCTLicensedStates
Licensed StatesDELicensedStates
Licensed StatesDCLicensedStates
Licensed StatesFLLicensedStates
Licensed StatesGALicensedStates
Licensed StatesHILicensedStates
Licensed StatesIDLicensedStates
Licensed StatesILLicensedStates
Licensed StatesINLicensedStates
Licensed StatesIALicensedStates
Licensed StatesKSLicensedStates
Licensed StatesKYLicensedStates
Licensed StatesLALicensedStates
Licensed StatesMELicensedStates
Licensed StatesMDLicensedStates
Licensed StatesMALicensedStates
Licensed StatesMILicensedStates
Licensed StatesMNLicensedStates
Licensed StatesMSLicensedStates
Licensed StatesMOLicensedStates
Licensed StatesMTLicensedStates
Licensed StatesNELicensedStates
Licensed StatesNVLicensedStates
Licensed StatesNHLicensedStates
Licensed StatesNJLicensedStates
Licensed StatesNMLicensedStates
Licensed StatesNYLicensedStates
Licensed StatesNCLicensedStates
Licensed StatesNDLicensedStates
Licensed StatesOHLicensedStates
Licensed StatesOKLicensedStates
Licensed StatesORLicensedStates
Licensed StatesPALicensedStates
Licensed StatesPRLicensedStates
Licensed StatesRILicensedStates
Licensed StatesSCLicensedStates
Licensed StatesSDLicensedStates
Licensed StatesTNLicensedStates
Licensed StatesTXLicensedStates
Licensed StatesUTLicensedStates
Licensed StatesVTLicensedStates
Licensed StatesVALicensedStates
Licensed StatesWALicensedStates
Licensed StatesWVLicensedStates
Licensed StatesWILicensedStates
Licensed StatesWYLicensedStates

Events Information EventsInformation

FieldValueIRS element (for citing)
Name Of Event1GBL RACE FR CURNameOfEvent1
Gross Receipts Event15201090GrossReceiptsEvent1
Charitable Contributions Event13693202CharitableContributionsEvent1
Gross Revenue Event11507888GrossRevenueEvent1
Non Cash Prizes Event18964NonCashPrizesEvent1
Food And Beverage Event120675FoodAndBeverageEvent1
Other Direct Expenses Event1151504OtherDirectExpensesEvent1
Name Of Event23 DAY WALK SENameOfEvent2
Gross Receipts Event275691853GrossReceiptsEvent2
Charitable Contributions Event272388318CharitableContributionsEvent2
Gross Revenue Event23303535GrossRevenueEvent2
Non Cash Prizes Event218729NonCashPrizesEvent2
Rent Facility Costs Event22357598RentFacilityCostsEvent2
Food And Beverage Event22631330FoodAndBeverageEvent2
Other Direct Expenses Event25163101OtherDirectExpensesEvent2
Total Number Of Other Events2TotalNumberOfOtherEvents
Gross Receipts Other Events2714395GrossReceiptsOtherEvents
Charitable Contrib Other Events2549718CharitableContribOtherEvents
Gross Revenue Other Events164677GrossRevenueOtherEvents
Non Cash Prizes Other Events9682NonCashPrizesOtherEvents
Rent Facility Costs Other Events42435RentFacilityCostsOtherEvents
Food And Beverage Other Events221051FoodAndBeverageOtherEvents
Entertainment Other Events13300EntertainmentOtherEvents
Gross Receipts Total83607338GrossReceiptsTotal
Charitable Contributions Total78631238CharitableContributionsTotal
Gross Revenue Total Events4976100GrossRevenueTotalEvents
Non Cash Prizes Total Events37375NonCashPrizesTotalEvents
Rent Facility Costs Total Events2400033RentFacilityCostsTotalEvents
Food And Beverage Total Events2873056FoodAndBeverageTotalEvents
Entertainment Total Events13300EntertainmentTotalEvents
Other Direct Expenses Total Events5314605OtherDirectExpensesTotalEvents
Direct Expense Summary Events10638369DirectExpenseSummaryEvents
Net Income Summary-5662269NetIncomeSummary

Form990 Schedule G Part IV Form990ScheduleGPartIV

FieldValueIRS element (for citing)
IdentifierFundraising EventsIdentifier
Return ReferenceSchedule G, Part II Net income summaryReturnReference
ExplanationGross receipts are reduced by the amount of contributions per IRS instructions. The contributions for FY 2012 were $78.6 million.Explanation

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records MaintainedtrueRecordsMaintained

Recipient Table RecipientTable (197 entries)

Address Line1AddressUS/AddressLine1Address Line2AddressUS/AddressLine2CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrant
Adventist Healthcare Inc
1801 Research BlvdSuite 300RockvilleMD20853521532556501(c)3343875Screening
African Wellness Center
186903 Nathans PlaceMontgomery VillageMD20886510622960501(c)325000Screening
Albert Einstein College of Med Yeshiva University
1300 Morris Park AveBronxNY10461131624225501(c)3318000
Alexandria Neighborhood Health Services
2 East Glebe RoadAlexandriaVA22305541849891501(c)325000Education
American Association for Cancer Research
615 Chestnut StPhiladelphiaPA191064404236251649501(c)3830000Education
American Association on Health & Disabil
110 N Washington StRockvilleMD20854521884887501(c)3150000Education
American Jewish Joint
711 Third AvenueNew YorkNY100174014131656634501(c)3388964Education
Arlington Free Clinic
2921 11th Street SouthArlingtonVA22204541671883501(c)3150000Education
Aultman Hospital
26210 Emery RDClevelandOH44128341445390501(c)3200000Research
Baylor College Medicine
One Baylor PlazaHoustonTX77030741613878501(c)31438930Research
Beckman Research Inst City of Hope
1500 E Duarte RdDuarteCA91010953432210501(c)320981Research
Beth Israel Deaconess Medical Center
330 Brookline AvBostonMA02215042103881501(c)3120000Research
Bioethics International
420 Lexington AveNew YorkNY10170870774767501(c)360000Education
Boise State University
1910 University DrBoiseID83725826010706501(c)3200000Research
Boston University
580 Harrison Ave 3-WBostonMA02118042103547501(c)359138Research
Boston University School of Medicine
85 East Newton StBostonMA02118042103547501(c)360000Research
Brigham & Women's Hospital
PO Box 3149BostonMA022413149042312909501(c)3244788Research
Brown University
Box 1929 164 Angell StProvidenceRI02912050390989501(c)3200000Research
Burnham Institute for Medical Research
10901 N Toerrey Pines RdLa JollaCA92037510197108501(c)3210000Research
California Pacific Medical Center
475 Brannan StSan FranciscoCA94107942728423501(c)3287018Research
Cancer Care
275 Seventh AvenueNew YorkNY10001131825919501(c)3634481Treatment
Cancer Legal Resource Foundation
919 Albany StreetLos AngelesCA90015952960607501(c)37500Education
Capital Breast Care Center
650 Pennsylvania AveWashingtonDC20003530196603501(c)3150000Education
CASA of Maryland
734 University BlSilver SpringMD20903521372972501(c)3186875Education
Case Western Reserve University
10900 Euclid AvenueClevelandOH44106341018992501(c)3216048Research
C-Change
1776 I St NWWashingtonDC20006161641769501(c)350000Education
Children's Hospital Boston
PO Box 414413BostonMA02241042774441501(c)3120000Research
Children's Memorial Hospital
225 E ChicagoChicagoIL60611363357005501(c)348000Research
Cleveland Clinic Foundation
9500 Euclid AvClevelandOH44195912153073501(c)360000Research
Cold Spring Harbor Laboratory
1 Bungtown RdCold Spring HarborNY11724112013303501(c)3198000Research
Columbia University Medical Center
722 West 168th StNew YorkNY10032135598093501(c)3417527Research
Commonweal
PO Box 316BolinasCA94924942366094501(c)368148Education
Conquer Cancer Foundation
2318 Mill RoadAlexandriaVA22314311667995501(c)3250000Education
Cornell University Weill Medical College
1300 York AvNew YorkNY10065136094042501(c)340000Research
Cornell University Ithaca
120 Day HallIthacaNY14853150532082501(c)340000Research
Dana Farber Cancer Institute
450 Brookline Ave BP 412BostonMA02215042263040501(c)32532935Research
Dartmouth College
63 South Main StHanoverNH03755020222111501(c)3207145Research
Delta State University CCED
1417 College StClevelandMS38733646026565501(c)320000Education
Duke University Medical Center
2200 W Main St Ste 820DurhamNC27705560532129501(c)32237111Research
ECOG Research and Education Foundation
1818 Market StPhiladelphiaPA19109391723095501(c)3171200Research
Emory University Winship Cancer Inst
PO Box 935084AtlantaGA31193580566256501(c)360000Research
EO Lawrence Berkeley National Laboratory
University of CaliforniaBerkeleyCA94701942951741501(c)3200000Research
Facing Our Risk of Cancer Empowered
16057 Tampa Palms BlvdTampaFL33647650927702501(c)3100000Education
Fannie Lou Hamer Cancer Foundation
2600 Browning RoadGreenwoodMS38930861118042501(c)320000Education
Fox Chase Cancer Center
333 Cottman AvenuePhiladelphiaPA19111223524939501(c)360000Research
Fred Hutchinson Cancer Research Center
1100 Fairview Av NSeattleWA98109563744111501(c)3600000Research
Friends of Cancer Research
2231 Crystal DrArlingtonVA22202521983273501(c)335000Education
George Washington University
45155 Research PlAshburnVA20147530196584501(c)3106927Research
Georgetown U
Bldg D NWWashingtonDC200571411530196603501(c)31429076Research
Harvard Medical School
1350 Massachusetts AvCambridgeMA02138042103580501(c)3348581Education
Harvard University
25 Shattuck StreetBostonMA02115042103580501(c)360000Research
Henry Ford Health System
1 Ford Place 5EDetroitMI48202381357020501(c)3199616Research
Herald Cancer Association
715 E Mission RoadSan GabrielCA91776133156738501(c)370000Education
Holy Cross Hospital
1500 Forest Glen RdSilver SpringMD20910590791028501(c)3250000Education
Indiana U (Indianapolis)
PO Box 66057IndianapolisIN462666057356001673501(c)31771825Research
Inova Health System Foundation
2700 Prosperity AvenueFairfaxVA22031541071867501(c)375000Education
International Breast Cancer
660 John Nolan DrMadisonWI53711391766858501(c)3146394Research
International Scholarship & Tuition Serv
200 Crutchfield AveNashvilleTN37210621247492501(c)3294251Education
John Wayne Cancer Institute Molecular Oncology
2200 S Monica BlvdSanta MonicaCA90404954291515501(c)380000Research
Johns Hopkins U
1101 East 33rd StBaltimoreMD21218520595110501(c)32511037Research
Karmanos Cancer Institute
4100 John RDetroitMI48201381613280501(c)3213035Research
Korean Community Service Center of Greater WA
7700 Lt River TurnpikeAnnandaleVA22003113186054501(c)390000Education
Lankenau Institute for Medical Research
100 Lancaster AveWynnewoodPA19096232175659501(c)3391460Research
Lawrence Berkeley National Laboratory
PO Box 528BerkeleyCA94701942951741501(c)357914Research
Loyola University
820 N Michigan AveChicagoIL60611361408475501(c)3159554Research
Mary's Center for Maternal & Child Care Inc
2333 Ontario Road NWWashingtonDC20009521594116501(c)3100000Education
Massachusetts General Hospital
101 Huntinton Ave Ste 3BostonMA02199042697983501(c)3425721Research
Mayo Clinic and Foundation
4500 San Pablo RdJacksonvilleFL32224416011702501(c)3350000Research
Mayo Clinic Jacksonville
4500 San Pablo RdJacksonvilleFL32224416011702501(c)3220003Research
Mayo Clinic Rochester
200 First St SWRochesterMN55903416011702501(c)3832022Research
Mazzoni Center
21 S 12th StPhiladelphiaPA19107232176338501(c)310000Research
Medical College
8701 Watertown Plk RdMilwaukeeWI53226390806261501(c)3200000Research
Memorial Sloan-Kettering Cancer Ctr
1275 York AveNew YorkNY10021131924236501(c)3747114Research
Mercy Health Foundation
301 St Paul PlaceBaltimoreMD21202522173656501(c)315000Research
Mercy Medical Center
301 St Paul PlaceBaltimoreMD21202520591658501(c)3348806Research
Methodist Hospital Research Institute
6565 FanninHoustonTX77030870721923501(c)359930Research
Metropolitan Chicago Breast Cancer
1645 Jackson BlvdChicagoIL60612262264895501(c)3424999Screening
Michigan State University
301 Admin BldgEast LansingMI48824386005984501(c)3150000Research
Mississippi State Department of Health
570 E Woodrow WilsonJacksonMS39215646000775501(c)346239Education
Mount Sinai School of Medicine
1 Gustave L Levy PlNew YorkNY10029136171197501(c)3439957Research
Muslim Community Center Medical Clinic
15200 Newhampshire AveSilver SprMD20905521072792501(c)324990Screening
National Academy of Sciences
730 15th Street NWWashingtonDC20005530196932501(c)38139Research
National Cancer Institute
Building 31 Room 11A-48BethesdaMD20892521986675501(c)3500000Research
New York University
665 BroadwayNew YorkNY10012135562308501(c)340000Research
New York University School of Med
One Park AveNew YorkNY10016135562308501(c)3320000Research
Northwestern Univ - Evanston
633 Clark StEvanstonIL60208362167817501(c)3359936Research
NOVA Research Company
4600 EW HighwayBethesdaMD20814521477125501(c)36800Education
Nueva Vida
2000 P Street NWWashingtonDC20036251410081501(c)3100000Education
Ohio State University College of Med
333 West 10th AveColumbusOH43210316025986501(c)3120000Research
Oregon Health & Science University
0690 SW Bancroft StPortlandOR97239237083114501(c)3566171Research
Patient Advocate Foundation
421 Butler Farm RdHamptonVA23666541806317501(c)31000000Treatment
Penfold-Patterson Research Institute
1700 El Camino RealMenlo ParkCA94025270578063501(c)3400000Research
Pennsylvania State Univ College of Medi
H138 500 University DrHersheyPA17033236298308501(c)3160344Research
Prevent Cancer Foundation
1600 Duke StreetAlexandriaVA22314521429544501(c)399950Education
Primary Care Coalition-Montgomery Cty Inc
8757 Georgia AveSilver SpringMD20910521847976501(c)3561745Screening
Prince George's County Health Dept
1801 McCormick DrLargoMD20774522046026501(c)340000Education
Princeton University
701 Carnegie CenterPrincetonNJ08540210634501501(c)3256250Research
Proteogenomics Research Institute
11107 Roselle StSan DiegoCA92121800418281501(c)3200000Research
Providence Health Foundation
1150 Varnum Street NEWashingtonDC20017521275583501(c)3500000Screening
Providence Portland Medical Center
PO Box 13993PortlandOR97213930386906501(c)3197963Research
Purdue University
23510 Network PlaceChicagoIL60673356002041501(c)379979Research
Quantum Leap HealthCare Collaborative
320 Fairway DriveHalf Moon BayCA94019204284925501(c)338000Education
ReaganUdall Foundation
800 I Street NWWashingtonDC20001263727917501(c)390000Education
Research Advocacy Network
6505 W Park BlvdPlanoTX75093352209499501(c)379440Education
Research Foundation of SUNY
35 State StreetAlbanyNY12207141368361501(c)348000Research
Roswell Park Alliance Foundation
Roswell Pk Cancer InstBuffaloNY14263161391608501(c)320000Research
Sanford Research
2301 East 60th St NSioux FallsSD57104363297853501(c)3120000Research
Scripps Research Institute
10550 N Torrey Pines RdLa JollaCA92037330435954501(c)3105000Research
Smith Farm Center for Healing & the Arts
1632 U Street NWWashingtonDC20009521977976501(c)3233333Education
Society for Surgical Oncology
85 W Algonquin RdArlington HtsIL60005136161070501(c)357500Research
Society for Women's Health Research
1025 Connecticut Av NWWashingtonDC20036521694732501(c)3755015Research
Southern Illinois University
PO Box 19616SpringfieldIL62794376005961501(c)311982Research
Stanford University
PO Box 44253San FranciscoCA94144941156365501(c)3553082Research
SUNY at Buffalo
402 Crofts HallBuffaloNY14260166020461501(c)3115798Research
SUNY at Stony Brook
PO Box 9AlbanyNY12201141368361501(c)3467432Research
The ASCO Cancer Foundation
1900 Duke StAlexandriaVA22314311667995501(c)32475000Education
The General Hospital Corp
50 Staniford STBostonMA02114041564655501(c)3983687Research
The Hope Foundation
PO Box 483Ann ArborMI48106742655302501(c)3683200Research
The Mautner Project
1300 19th Street NWWashingtonDC20036521703915501(c)3100000Education
The Ohio State University College
700 Childrens DrColumbusOH43205381746722501(c)324868Research
The Red Devils
PO Box 36291TowsonMD21286743070929501(c)350000Treatment
The Salk Institute
10010 N Torrey Pines RdLa JollaCA92037956136024501(c)3200000Research
The University of Chicago
970 East 58th STChicagoIL60637362177139501(c)3200000Research
The Wistar Institute
3601 Spruce StreetPhiladelphiaPA19104236434390501(c)3174797Research
Thomas Jefferson University
201 S 11th StPhiladelphiaPA19107232840151501(c)31991793Research
Tom Lantos Foundation for Human Rights
19 Pleasant StreetConcordNH03301352325429501(c)310000Education
Translational Genomics Research Institute
445 N Fifth StreetPhoenixAZ85004753065445501(c)388637Research
Trustees of Boston University
25 Buick StreetBostonMA02215042103547501(c)3158858Research
Trustees of Columbia Univ
722 West 168 StNew YorkNY10032133957095501(c)3200000Research
Tufts University
136 Harrison AveBostonMA02111043532914501(c)3436760Research
Univ of Arkansas for Medical Science
4301 W MarkhamLittle RockAR72205716056774501(c)319531Education
Univ of Colo Denver Health Sciences Ctr
PO Box 910238DenverCO80291846000555501(c)3648146Research
Univ of Kentucky Research Foundation
PO Box 931113ClevelandOH41193616033693501(c)3491553Research
Univ of Louisville Rsrch Foundation Inc
521 Stevenson HallLouisvilleKY40292611029626501(c)3107978Research
Univ of North Carolina at Chapel Hill
104 Airport DrChapel HillNC27599566001393501(c)3547256Research
Univ of North Carolina at Charlotte
9201 Univ Cty BlvdCharlotteNC28223566059417501(c)360000Research
Univ of Southern California
1540 Alcazar StreetLos AngelesCA90033951642394501(c)3210869Research
Univ of Texas MD Anderson Cancer Center
PO Box 4390HoustonTX772104390746001118501(c)31801398Research
Univ of PA School of Medicine
3451 Walnut StreetPhiladelphiaPA19104231352685501(c)3120000Research
University Miami School of Medicine
Offc of Exp CompMiamiFL33136590624458501(c)3885904Research
University of Alabama at Birmingham
1720 2nd Avenue SouthBirminghamAL35294636005396501(c)31704949Research
University of Arizona
PO Box 44390TucsonAZ85733742652689501(c)320000Research
University of California - Santa Cruz
1156 High StreetSanta CruzCA95064941539563501(c)360000Research
University of California - Davis
PO Box 989062West SacramentoCA95798946036494501(c)3449157Research
University of California - Irvine
Biological Science 3IrvineCA92697952226406501(c)3260000Research
University of CA - San Diego
9500 Gilman DrLa JollaCA92093956006144501(c)3695698Research
University of California - San Francis
3333 California StSan FranciscoCA94118946036493501(c)33400047Research
University of California - Los Angeles
10920 Wilshire BlvdLos AngelesCA90024956006143501(c)3535000Research
University of Central Florida
12424 Research PkwyOrlandoFL32828593086453501(c)3349442Research
University of Cincinnatti
51 Goodman DrCincinnatiOH45221316000989501(c)3420582Research
University of Colorado Health Sciences C
13001 E 17th PlAuroraCO80045846000555501(c)3166085Research
University of Florida
219 Grinter HallGainesvilleFL32611590974739501(c)3160000Research
University of Hawaii
2530 Dole StreetHonoluluHI96822996000354501(c)39880Research
University of Houston
PO Box 988HoustonTX77001746001399501(c)3264726Research
University of Illinois at Chicago
809 S Marshfield AveChicagoIL60608376000511501(c)3328466Research
University of Iowa at Carver College
B5 Jessup HallIowa CityIA52242426004813501(c)348000Research
University of Kansas Medical Center
3901 Rainbow BlvdKansas CityKS66160481108830501(c)3612646Research
University of Louisville
521 Stevenson HallLouisvilleKY40292611029626501(c)3467440Research
University of Maryland at Baltimore
PO Box 41428BaltimoreMA20203311678679501(c)3770001Research
University of Massachusetts Amherst
Goodell Bldg Box 33210AmherstMA01003542084125501(c)36587Research
University of Michigan
Wolverine TowerAnn ArborMI481091274386006309501(c)32112387Research
University of Minnesota
200 Oak St SEMinneapolisMN55455416007513501(c)3950279Research
University of Missouri
341 Woods HallSt LouisMO63121436003859501(c)327194Research
University of Nebraska
985100 Nebraska Med CtrOmahaNE68198470049123501(c)3280000Research
University of North Carolina
104 Airport DrChapel HillNC27599566001393501(c)3176232Research
University of North Dakota
264 Centennial DrGrand ForksND58202203332779501(c)340000Research
University of Oklahoma Health Sciences C
1100 N LindsayOklahoma CityOK73104736017987501(c)3216127Research
University of Pennsylvania
3451 Walnut StPhiladelphiaPA19104231352685501(c)3260000Research
University of Pittsburgh
139 University PlacePittsburghPA15260250966691501(c)3308000Research
University of Portland
5000 N Willmette BlvdPortlandOR97203930401259501(c)350000Education
University of Rochester
1325 Mt Hope AveRochesterNY14620160743209501(c)329986Research
University of South Dakota
2301 East 60th St NSioux FallsSD57104466018891501(c)3197098Research
University of Southern California
1540 Alcazar StreetLos AngelesCA90033951642394501(c)360000Research
University of Tennessee
1924 Alcoa HwyKnoxvilleTN37920311626179501(c)3212608Research
University of Texas at Health Science CTR
7000 Fannin StreetHoustonTX77030741586031501(c)3254820Research
University of Texas Health Science Ctr
7703 Floyd Curl DrSan AntonioTX78229741761309501(c)3200000Research
University of Utah
75 South 2000Salt Lake CityUT84112876000525501(c)386179Research
University of Vermont
85 S Prospect StBurlingtonVT05405030179440501(c)3126958Research
University of Virginia
PO Box 400195CharlottesvilleVA22904541682176501(c)3229920Research
University of Washington
3917 University Way NESeattleWA98105916001537501(c)3653190Research
University of Wisconsin - Madison
21 North Park StMadisonWI53715396006492501(c)3547009Research
UNT Health Science Center
3500 Camp Bowie BlvdFort WorthTX76107756064033501(c)360000Research
UT HSC - San Antonio
7703 Floyd Curl DrSan AntonioTX77229741586031501(c)3220000Research
UT HSC - Houston
PO Box 203382HoustonTX77216741761309501(c)331257Research
UT Southwestern Medical Center at Dallas
PO Box 841753DallasTX752841753756002868501(c)3128924Education
UTMD Anderson Cancer Ctr
1515 Holcombe BlvdHoustonTX770304009746001118501(c)35002462Research
Vanderbilt University Medical Center
3319 West End AveNashvilleTN372038480620476822501(c)3932235Research
Vietnamese Resettlement Association
6131 Willston DrFalls ChurchVA22044541512549501(c)3100000Education
Wake Forest Baptist Med Center
Medical Ctr BlvdWinstonSalemNC27157560552787501(c)311837Research
Wake Forest University Health Sciences
Medical Center BlvdWinstonSalemNC27157223849199501(c)3200000Research
Washington Cancer Institute
110 Irving Street NWWashingtonDC20010521791670501(c)3150000Education
Washington University at St Louis
660 S Euclid AveSt LouisMO63110430653611501(c)33371090Research
Wayne State University
5057 Woodward Ave13th FlDetroitMI48202383555142501(c)3365652Research
Weill Medical College of Cornell Univ
575 Lexington AvenueNew YorkNY10022136094042501(c)348000Research
West Virginia University
886 Chestnut Ridge RdMorgantownWV26506550665758501(c)3450000Research
Whitehead Inst for Biomedical Research
9 Cambridge CenterCambridgeMA02142061043412501(c)3264000Research
Yale University
47 College StreetNew HavenCT06510060646973501(c)3844974Research
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants182TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations0TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierForm 990, Schedule IIdentifier
Return ReferenceDescription of Organization's Procedures for Monitoring the Use of GrantsReturnReference
ExplanationSusan G. Komen for the Cure's (the Organization) policies for managing research grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the peer review and funding process. Throughout the term of the grant, scientific progress is monitored by a Science Manager assigned to the grant. Grantee is required to submit scientific progress reports on each anniversary of the grant start date for the duration of the project, except for the final year of the grant when a final report is due no later than 30 days after the end date of the grant term. An annual scientific progress report also is due if the Grantee is requesting an extension to the end of the grant term or acceleration of the Grant term. Progress reports must include the following sections: Hypothesis and Specific Aims: A description of progress made during the reporting period for each Aim, data supporting the described progress, justification for delays, the projected completion date for research addressing the specific aim, and current status. Research Outcome Highlight: A list of the research accomplishments during the reporting period. Publications, Presentations & Posters: A list of all manuscripts submitted during the reporting period that are related to the research project, in press or published, with full citation information and a list of all posters displayed or presentations delivered at scientific meetings during the reporting period. Patents, Products, Copyrights & Intellectual Property: A list of all patents or patent applications filed during the reporting period and a list of specific research products developed during the reporting period. Examples of products include novel therapeutic targets, biomarkers, vectors, novel therapies, risk assessment tools and/or algorithms, new technologies, educational materials, etc. Professional Awards & Promotions: A list of all professional awards and promotions received by any of the key personnel during the reporting period. Research Conclusions (Final Reports Only): A brief narrative followed by a bulleted or numbered list of the key outcomes, research accomplishments, and conclusions for the research project; a brief description of the future prospects or next steps in the line of inquiry; a summary evaluating the impact of Komen funding on the research, and for training grants, on the career development of the trainee. Scientific progress reports are submitted online via proposal CENTRAL using the templates provided by Komen. With reasonable prior notice to Grantee, the Organization may require additional reporting from Grantee and also may require Grantee to participate in site visits, telephone conferences, presentations or other speaking engagements. All Grant funds must be expended in accordance with the project's approved budget. Komen will disburse the first year's budgeted Grant funds within thirty (30) days of the effective date of the Grant. For each additional year, excluding the final year of the Grant term, Komen will disburse one hundred percent (100%) of the budgeted funds for that year after review and approval of a satisfactory and timely scientific progress report and financial report for the prior year, updated IACUC/IRB approvals (as applicable), and any other documents requested by Komen for its approval. For the final year of the Grant, Komen will disburse eighty percent (80%) of the approved budget funds after review and approval of a satisfactory scientific progress report and financial report for the prior year, and the submission of updated IACUC/IRB (as applicable), and any other documents requested by Komen for approval. The remaining twenty percent (20%) of funds will be disbursed upon receipt of a satisfactory final research report, final financial report, and any other documents required by Komen. As part of its oversight of research progress, Komen may adjust the project reporting period and associated disbursement of Grant funds at any time during the Grant term with prior written notice to Grantee. Annual financial reports are due no later than 30 days after each anniversary of the Grant start date for the duration of the grant term, with the exception of the final financial report, which is due no later than 60 days after the end date of the Grant term. All expenditures must be reported in United States dollars ($USD). Grantee must submit a Request for Budget Change form in PC in the event Grantee wishes to move funds across budget categories in excess of the allowable limits. Any unexpended funds must be remitted with final financial report to the Organization, unless otherwise directed by the Organization. Komen will not be responsible for a) any expenditure made prior to the effective date or after the termination of the Grant, b) commitments made during the Grant term but not paid within sixty (60) days following the expiration of the Grant Agreement, c) expenditures that are not permitted as described within the RFA, or d) any expenditure that is inconsistent with the approved Research Plan and budget or that exceeds the total amount of the Grant. Komen or its designated representatives shall have the right to request and receive from the Grantee Institution and PI, Co-PI and Mentor, as well as the institutions and principal investigators, co-principal investigators and mentors involved in any consortium or subcontract, copies of any and all documents and other information related to the Grant at any time during or after the term of the Grant. This right includes, but is not limited to, the right to review all financial books and records related to the Grant and to perform an audit or other accounting procedures of all expenses related directly or indirectly to the Grant. The Organization's policies for managing community grants and other non-research related grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the peer review and funding process. All grantees must sign a grant contract which sets forth the terms of the grant, including the purpose of the grant, amount, budgetary restrictions, duration payment schedule, reporting requirements, and audit and early termination rights for the Organization. The grantee is required to submit progress reports (typically every six months) that detail progress towards meeting each of the objectives and any challenges encountered. The report must also include a full accounting of grant funds awarded (actual versus budgeted expenses). The Program Manager conducts site visits with the grantees when appropriate to build a stronger relationship with the grantee; to gain a better understanding of its work; and to address any challenges or problems the grantee is facing. Any changes to the project must be approved by the Organization's Program Manager in writing in advance of the change. A final report must be provided within 45 days after the completion or early termination of the grant and must include evaluation of the program's accomplishments and impact in the community. Any unexpended funds must be remitted with the final report and final financial report to the Organization unless otherwise directed by the Organization.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelXFirstClassOrCharterTravel
Written Policy Re T And E ExpensestrueWrittenPolicyReTAndEExpenses
Substantiation RequiredtrueSubstantiationRequired
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Form990 Of Other OrganizationsXForm990OfOtherOrganizations
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance PaymenttrueSeverancePayment
Supplemental Nonqual Retire PlanfalseSupplementalNonqualRetirePlan
Equity Based Comp ArrangementfalseEquityBasedCompArrangement
Comp Based On Revenue Of Filing OrgfalseCompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related OrgsfalseCompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing OrgtrueCompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate OrgsfalseCompBasedNetEarningsRelateOrgs
Any Non Fixed PaymentsfalseAnyNonFixedPayments
Initial Contract ExceptionfalseInitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (12 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
Nancy G Brinker
5487650124450011502010195012350696147000
Elizabeth Thompson
3217260510000252009980069720392198000
Katrina McGhee
27706803975002206010056023170331397000
Mark Nadolny
28937904413704180013528075910358815000
Jonathan Blum
20086203386301296090100660103070384707000
Lesley Lurie
16785001544502132010124046870200238000
Eric Winer
1838420270000000000210842000
Julie Teer
2029310254500199700000230378000
David Dawson
1957590223250204509248069720236349000
Margo Lucero
153513017650019520107150104720194302000
Chandini Portteus
15484301467001691010448045580186210000
Nancy Macgregor
17396402145003400012015047720215601000

Form990 Schedule J Part III Form990ScheduleJPartIII

FieldValueIRS element (for citing)
IdentifierSupplemental Compensation InformationIdentifier
Return ReferenceSchedule J, Part I, Line 1aReturnReference
ExplanationFirst class and business class fares for domestic travel, Canada, the Caribbean, Central America, and Mexico are not reimbursable. However, personal frequent flier mileage and/or coupons may be used for no-cost upgrades. Only the CEO/Founder is approved for first class travel. Whenever possible, discounted first class and upgrades are used to minimize cost. Schedule J, Part I, line 4a A severance payment was made to Jonathan Blum during calendar year 2011. Schedule J, Part I, Line 6a The Smartpay Incentive Plan is designed to drive organizational performance, enhance the organization's competitive pay position and positively affect our ability to attract and retain talent. Currently annual operational financial performance at headquarters must provide full funding of the board approved budgeted slate of research grants and mission activity while ensuring adjusted net operating activity remains at breakeven. This Smartpay Incentive Plan is an annual program, giving full discretion to the organization's board of directors for renewal, suspension, or termination of the plan. The Smartpay Incentive Plan is available to all employees of the parent who meet eligibility requirements. $1,301,999 was paid out during calendar year 2011.Explanation

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArt
Art Historical TreasuresArtHistoricalTreasures
Art Fractional InterestArtFractionalInterest
Books And PublicationsBooksAndPublications
Clothing And Household GoodsClothingAndHouseholdGoods
Cars And Other VehiclesCarsAndOtherVehicles
Boats And PlanesBoatsAndPlanes
Intellectual PropertyIntellectualProperty
Securities Publicly TradedSecuritiesPubliclyTraded
Securities Closely Held StockSecuritiesCloselyHeldStock
Securities Prtnrshp Trust IntrstsSecuritiesPrtnrshpTrustIntrsts
Securities MiscellaneousSecuritiesMiscellaneous
Qualified Contrib Hist StructQualifiedContribHistStruct
Qualified Contrib OtherQualifiedContribOther
Real Estate ResidentialRealEstateResidential
Real Estate CommercialRealEstateCommercial
Real Estate OtherRealEstateOther
CollectiblesCollectibles

Food Inventory FoodInventory

FieldValueIRS element (for citing)
Non Cash CheckboxXNonCashCheckbox
Number Of Contributions3NumberOfContributions
Noncash Contribs Rptd F99043770NoncashContribsRptdF990
Method Of Determining Revenuescost or sale priceMethodOfDeterminingRevenues
FieldValueIRS element (for citing)
Drugs And Medical SuppliesDrugsAndMedicalSupplies
TaxidermyTaxidermy
Historical ArtifactsHistoricalArtifacts
Scientific SpecimensScientificSpecimens
Archaeological ArtifactsArchaeologicalArtifacts

Other Non Cash Contributions Table OtherNonCashContributionsTable (2 entries)

Non Cash CheckboxNonCashCheckboxDescriptionDescriptionNumber Of ContributionsNumberOfContributionsNoncash Contribs Rptd F990NoncashContribsRptdF990Method Of Determining RevenuesMethodOfDeterminingRevenues
XDesk1150cost or sale price
XGolf putters,hd cov,pouches105028150cost or sale price
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeld
Review Process Unusual NC GiftstrueReviewProcessUnusualNCGifts
Third Parties UsedfalseThirdPartiesUsed

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (5 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
VolunteersForm 990, Part I, Question 6Volunteers serve in a variety of ways but the greatest number of volunteers assist with the Breast Cancer 3 Day series.
Program Service AccomplishmentsPart IIINancy G. Brinker promised her dying sister, Susan G. Komen, that she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure (Komen) and launched the global breast cancer movement. Today, Susan G. Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Race for the Cure, Komen and its Affiliates have invested $2.2 billion to fulfill its promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. A - Research and Training Komen has contributed to major advances in breast cancer research over the past 30 years. Komen's Research Programs are designed to advance the translation of research discoveries into new ways to diagnose, treat, and prevent breast cancer, leading to a reduction of breast cancer incidence and mortality within the next decade. To ensure maximum impact for its research dollars, Komen is guided by a Scientific Advisory Board, a group of internationally recognized doctors, scientists and advocates, and consults with the Komen Scholars, a group comprised of 68 scientists and advocates. Komen awards grants to individual scientists, research teams, and organizations around the world through competitive, review processes that ensure maximum impact for our research dollars. In fiscal year 2012, Komen made 144 grants through its Research and Training Grants Program to support research and training in the United States and other countries, including Australia, Belgium, and Canada. The following Request for Applications (RFA) driven grant opportunities were offered by Komen during fiscal year 2012: -Promise Grants: Large-scale grants, up to $4.2 million each, during a three-year period, targeted to research that seeks to understand and prevent late recurrence of breast cancer. -Post-Doctoral Fellowships: Grants of $60,000 per year for two or three years, to attract, train, and retain promising young researchers into the field of breast cancer research. -Career Catalyst Research: Grants of $150,000 per year for two to three years, to fill a critical gap in support and stimulate the transition from training to independence among promising cancer investigators. -Investigator Initiated Research: Grants of up to $25,000 per year for three to four years, to explore new ideas and approaches with significant potential to lead to reductions in breast cancer mortality and/or incidence within the decade. -Post Baccalaureate in Disparities Research: Grants up to $135,000 per year over three years, to support training programs for graduate students in the area of breast cancer disparities in breast cancer outcomes across population groups. The grant slate approved for funding through the above-referenced opportunities is comprised of the following: -The majority of the grants will address important questions related to the biology of breast cancer (46%), including understanding chromosomal changes in the initiation of breast cancer, the role of oncogenes and tumor suppressor genes. -Of the biology-based projects, the major focus of these projects is on breast cancer progression and metastasis. -Grants addressing methods for treatment, with significant focus on discovery and development of systemic therapies, are the second highest concentration of grants (27%) . -Grants addressing early detection, diagnosis and prognosis, with significant focus on biomarker discovery, validation, and application comprise 12% of the grant slate. -Grants addressing the exogenous and endogenous causes of breast cancer (etiology) comprise 5% of the grant slate. -Grants investigating issues related to cancer control, survivorship, and outcomes comprise 6% of the grant slate. -Grants focusing on strategies to prevent breast cancer, such as through the use of vaccines and personal behavior interventions, comprise 4% of the grant slate. Below are specific examples of promising research and training grants committed in fiscal year 2012: -A $4 million Promise Grant to Drs. Matthew Ellis and Pascal Meier, of Washington University in St. Louis to better identify which women with ER-positive disease are at highest risk for late recurrence, and then targeting those at high risk with more effective therapies. The team will study changes in the DNA structure of breast cancer cells versus normal cells, and develop better ways to kill the breast cancer cells before they spread. -A $4 million Promise Grant to Drs. Bert O'Malley and Kent Osborne, at Baylor College of Medicine in Houston, to identify women who will not benefit from the most commonly used therapies today - tamoxifen or aromatase inhibitors - and develop new therapies for women with this form of the disease. This study may lead to the first new drug in years to prevent recurrence in women with ER-positive breast cancer. -A $250,000 Scholar Grant to Dr. Anne McTiernan, of the Fred Hutchinson Cancer Research Center in Seattle, to investigate the incremental effect of vitamin D supplementation in overweight and obese postmenopausal women with low blood vitamin D levels on response to a weight loss (diet + exercise) intervention. The proposed research will provide important information about vitamin D insufficiency and weight, two potentially modifiable risk factors for breast cancer. -A $888,000 Investigator-Initiated Research Grant to Dr. Michelle Cote, of Wayne State University, to study markers to identify African American women at the highest risk for developing breast cancer. -A $250,000 Scholar Grant to Dr. Mary-Claire King, of the University of Washington in Seattle, to identify new genes that will better identify women at risk for inherited breast cancer -A $450,000 Career Catalyst Research Grant to Dr. Keith Bahjat, of Providence Portland Medical Center, to develop a vaccine against a gene commonly seen in HER-2 positive breast cancer, which represents 15 to 20 percent of breast cancer cases. The hope is to combine vaccine therapy with treatment drugs to prevent recurrence. -A $450,000 Career Catalyst Research Grant to Dr. Elisabeth Battinelli, of Brigham and Woman's Hospital in Boston, to understand why some blood-clot medicines like heparin are leading to prolonged survival and less metastatic disease in breast cancer patients. Komen also supported dozens of partnerships and special projects to advance research and our understanding of breast cancer around the world. These grants respond to unique opportunities, leverage the work of different organizations, and address critical challenges and cross-cutting issues in research, clinical practice, and public health. Examples of special projects committed in fiscal year 2012 include the following: RxPONDER: Rx for Positive Node, Endocrine Responsive Breast Cancer (SWOG-S1007) - $250,000 to provide funding for the cost of Oncotype DX testing for women participating in the Phase III clinical trial called RxPONDER (Rx for Positive Node, Endocrine Responsive Breast Cancer) who are uninsured or whose insurance companies will not reimburse for the test. The RxPONDER trial will help determine whether multi-gene tumor assays (Oncotype DX) can be used to identify women with node-positive breast cancer who could forego chemotherapy. Institute of Medicine (IOM) - Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population - $50,000 to support an IOM consensus study to examine issues in the quality of cancer care with an emphasis on shifting demographics in the US that will rapidly accelerate the number of new cancer diagnoses at a time when oncology workforce shortages are predicted. The study considers quality of care from the perspectives of key stakeholders, including patients, health care providers, and payers; examines opportunities for and challenges to the delivery of high quality cancer care to an aging population, including the impact of health care reform and disparities of care; and formulates recommendations for improvements.
Program Service Accomplishments (Contd)B - EducationKomen is a trusted source of breast health and breast cancer information for people all over the world and is instrumental in connecting people with the resources they need in their fight against breast cancer. Our award-winning website, www.komen.org, provides safe, accurate, comprehensive, and unbiased information about breast cancer based upon scientific evidence, as well as information about our research programs, community programs, volunteer opportunities, and events. The "Understanding Breast Cancer" section of the website, co-developed with Harvard Medical School faculty and Dana-Farber/Brigham and Women's Cancer Center staff, received over 2.5 million visits during fiscal year 2012. Komen also produced evidence-based, easy-to-read educational materials. Komen and its Affiliates distributed nearly 6 million educational materials in fiscal year 2012. Examples of Komen educational materials include the following: - Breast Self-Awareness cards in 19 languages for 22 specific audiences - General breast health awareness and breast cancer specific brochures and fact sheets - Booklets with support information for survivors and co-survivors Komen's trained and caring breast care helpline staff (1-877 GO KOMEN) provide answers to questions, local resources and moral support. Last fiscal year, the Susan G. Komen for the Cure breast cancer helpline responded to over 13,000 calls and 1,100 emails. While older African American women are less likely to be diagnosed with breast cancer than Caucasian women, they are more likely to die from the disease at every age. Susan G. Komen for the Cure's Circle of Promise program engages African American women, and black women around the world, in the fight against breast cancer. At the end of fiscal year 2012, a total of 100,000 ambassadors had been recruited to do the following: - Mobilize the community to ensure that women everywhere have access to the care they need; - Empower women to make a promise to reclaim their lives, their health and to be strong advocates in their communities; and - Dispel myths in the African American community that prevent women from getting early treatment for breast cancer. I AM THE CURE is an educational program that teaches simple, action-oriented, breast health information to participants in the Susan G. Komen Race for the Cure series. Last year, nearly 1.7 million people participated in a Race for the Cure event. A formal evaluation showed that 82% of participants recalled the message that early detection is key to survival. The mobile community education and outreach tour, Komen On the Go, shares important information about breast cancer with all generations across the country. From inner cities to community festivals, public universities to neighborhood centers, Komen On The Go signature bright pink vehicles are teaching Americans everywhere to take charge of their breast health and empowering participants to share information with friends and join the breast cancer movement. During fiscal year 2012, Komen on the Go was on exhibit for more than 87 days in 30 communities across the United States, educating more than 62,000 people with important breast health information and reaching nearly one million people through social media engagement. Cancer kills more people, worldwide, than TB, HIV/AIDS and malaria combined. Komen is waging the global fight against breast cancer by building and strengthening grassroots programs through networking, training, capacity building and financial support. In fiscal year 2012, 292 breast cancer advocates in six countries (Brazil, Costa Rica, Mexico, Panama, Romania, and Ukraine) were trained on the Community Educators program and Course for the Cure curricula. The Community Educators program is a theory-based trainer curriculum targeted for education program planners and Course for the Cure is a series of capacity building modules based on Komen's best practices and experience aimed at helping local non-government organizations increase their reach and impact. In partnership with the Caterpillar Foundation, grant programs in Brazil, Panama, and Mexico reached an estimated 4.6 million people through awareness campaigns and trained 2,715 community health workers, medical providers and Caterpillar employees on breast self awareness and breast cancer. Also, these grants provided for the distribution of 152,774 educational materials, 144 clinical breast exams, 745 mammogram referrals, and 89 mammograms. Komen also awarded grants for outreach programs in Bosnia and Herzegovina, Brazil, China, Egypt, Ghana, Hebron, Hungary, Israel, Jordan, Montenegro, Peru, Romania, Russia, South Africa, Switzerland, Taiwan, Ukraine, Zambia and for conferences in Lithuania and Spain.
Program Service Accomplishments (Contd)C - ScreeningGetting regular screening tests is the best way for women to lower their risk of dying from breast cancer. Screening tests can find breast cancer early, when it's most treatable. Komen supports free and low-cost mammogram programs in communities for women without health insurance or those with high co-pays and deductibles that make getting a mammogram too costly. In 2012, Komen awarded $4 million in new community grants to reach low-income, minority and uninsured women who fall through the healthcare gaps in the Washington, D.C. Metro area, where death rates from breast cancer continue to rank above national averages. The new Komen grants bring to 30 the number of Komen-funded programs in the D.C. area that strive to improve access and services to women facing breast cancer, representing a total in active grant funding of $11 million during 2011 and 2012. The five largest grants ($2,500,000 in 2012 and $1,917,000 in 2011) in the Washington, D.C. Metro area focus on addressing barriers to care caused by the area's overly fragmented heath care system. They encourage partnerships between providers in the region that establish a framework to ensure that patients can be easily and efficiently referred and "navigated" from screening all the way through to survivorship-with particular emphasis on removing obstacles to transportation and work obligations, wait times, and financial assistance. Fourteen grants ($2,779,981-eleven of which are continued from 2011; three of which are new in 2012) focus on patient education, including targeted breast health awareness outreach in a culturally sensitive manner that develops a better understanding of the importance of screening, the effectiveness of modern treatments and survivorship. Two grants ($400,000-programs continued from 2011) focus on provider education, helping doctors and other breast health providers develop a better understanding of the myths, fears and unique needs of the different cultural populations of the women they serve. The programs educate providers about updated screening guidelines, and how best to help refer patients through the complex web of screening, diagnosis, treatment and follow-up care. Two grants ($626,476 total in 2012 ) were awarded as part of the National Capital Area Continuum of Care Special Initiative. The purpose of this special funding initiative is to decrease the time it takes for a person to move from early detection and diagnosis to treatment and recovery; to increase mammography rates; change attitudes, knowledge and beliefs, and improve quality of life for patients going through treatment. Through Komen's National Vulnerable Populations Grants Program, Komen funds large-scale community grants that seek to improve quality of care, care coordination, and address unique barriers to breast care for disparate populations. Since the initiation of these grants in 2008, Komen has invested over $7 million in programs that aim to eliminate disparities in breast cancer mortality. The following are some examples of the projects funded in fiscal year 2012 through Komen's National Vulnerable Population Grants Program: Komen funded an initiative with four Consulates of Mexico in the United States to integrate breast health materials and education into their Ventanillas de Salud (Window of Health) program (VDS program). The initiative involves a new pilot program that aims to eliminate disparities in breast cancer mortality among Mexican, Mexican-American and Hispanic women in the U.S. As a part of this new initiative, Komen awarded a total of $200,000 to four separate fiscal agencies that partner with Mexican Consulates to operate each local VDS program. The initial phase of the initiative will help build organizational capacity in four select markets to address key breast health barriers that are unique to Latino populations. The initiative not only integrates breast health materials into the VDS program, but also increases the program's reach into the community. Komen also awarded a $500,000 grant to the American Association on Health and Disability to fund Project Accessibility USA: Removing Barriers for Women with Disabilities. The goal of the project is to work towards reducing breast cancer health disparities in women with disabilities by improving accessibility of screening sites; providing site specific recommendations to providers on strategies to ensure accessibility for women with disabilities; developing a web-based Resource Learning Center; and developing educational training modules on disability culture and sensitivity for healthcare professionals. Komen awarded $225,000 to the National Cancer Institute to sponsor the California Health Interview Survey (CHIS) breast cancer control data collection. CHIS is the largest and most comprehensive state health survey in the United States. CHIS provides the only robust breast cancer screening estimates for Asian Americans nationalities in the U.S. As no Asian women were interviewed about mammography in an Asian language in 2011, funding from Komen will allow Asian respondents to be interviewed during 2012, thereby capturing critical information to inform future research and programs to improve breast health for Asian Americans. Komen awarded $134,552 to Eastern Michigan University Foundation to fund the Healthy Asians American Project. This project will increase breast health awareness and access through trained lay health advisors in underserved areas throughout China and Taiwan. D - Treatment Countless numbers of patients delay or forgo breast cancer treatment each year, and as a result, these women are less likely to survive. For this reason, Komen supports programs that connect people with local resources, psychosocial support, and provide critical financial assistance. In 2012, Komen awarded a $500,000 grant to CancerCare to support the Linking A.R.M.S.TM (Assistance & Resources Made Simple) program. Linking A.R.M.S.TM is a program dedicated to providing financial assistance, education and support services to low-income, under- or uninsured breast cancer survivors. Funding for Linking A.R.M.S.TM provides direct financial assistance to approximately 1,336 breast cancer survivors for treatment-related expenses including pain and anti-nausea medication, lymphedema care, oral chemotherapy, durable medical equipment, childcare, and transportation to and from treatment. CancerCare also provides counseling and other support services that enable breast cancer patients to make informed treatment decisions, cope with the emotional effects of the disease, and experience an improved quality of life. In addition, Komen awarded a $1,500,000 grant to the Patient Advocate Foundation, a national non-profit organization that handles medical debt crisis management, for its Co-Pay Relief (CPR) program. The CPR program was launched in April 2004, providing direct financial assistance for pharmaceutical co-payments to patients with breast cancer, lung cancer and prostate cancer. Komen's funding, along with that of other key partners, will touch more than 10,000 breast cancer patients served through the program over the next two years. All told, Komen and its Affiliates have committed more than $1.8 billion to community programs since 1982, and in fiscal year 2012 partnered with almost 2,000 organizations to provide education, screening, treatment support and psychosocial programs. For more information about any of the accomplishments described here or to learn more about Susan G. Komen for the Cure, visit www.komen.org or call 1-877 GO KOMEN (1-877-465-6636).
Description of RelationshipsForm 990, Part VI, Question 2Eric Brinker, Board Member, is the son of Nancy G. Brinker, CEO and Board member. Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11b Management prepares the materials for the Form 990, with the assistance and review by external accountants. Senior levels of management review and comment on the final draft of the Form 990 for presentation to the audit committee of the board of directors. The audit committee of the Board of the Directors reviews and approves the Form 990 prior to being filed. Thereafter, each member of the Board of Directors receives an electronic copy of the Form 990 via email prior to the form being filed. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c The organization produces an annual survey requiring all employees, board members, committee members and advisory boards to inform on conflicts. Any conflicts are then reviewed by management and the audit committee and appropriate measures are taken. In addition, those same people have the obligation to update the conflict of interest statements during the year. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Question 15a and 15b The Compensation Committee of the Board of Directors assists the Board of Susan G. Komen for the Cure in overseeing compensation policies and practices. Responsibilities include oversight of the compensation of the President/ Chief Executive Officer, the range of compensation levels for the organization's other officers, disqualified persons, and other employees, granting the CEO authority to determine actual compensation levels within an approved range, and incentive/bonus compensation programs. The current policy was adopted in 2010. A formal Compensation Policy governs pay practices. Periodically, all positions in the organization are reviewed against external market data, engaging independent experts to conduct the benchmarking process. Compensation is then based upon comparable market rates of pay with consideration for internal equity and the financial position of the organization. For the CEO and officers of the organization, external benchmarking was conducted again this fiscal year to ensure market alignment. Salary increases, promotions or other forms of compensation are provided without regard to race, color, religion, gender, national origin, disability, veteran status or sexual orientation. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 The Organization's financial statements, conflict of interest policy and the 990 are publicly available on our website. The Articles of Incorporation are available from the Texas Secretary of State and other governing documents are made available as required by state law. Form 1023 is not online but available to the public upon request. ADDITIONAL DETAIL ON RACE PRODUCTION EXPENSES INCLUDED ON OTHER EXP LINE Form 990, Part IX, Line 24 THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. PURCHASES ALL T-SHIRTS FOR THE 133 RACES HELD BY THE KOMEN AFFILIATES DURING THE YEAR. Reconciliation of Net Assets Part XI, Line 5 Unrealized losses on investments = ($3,580,874) In Kind services Revenues = $13,250,636 In Kind services expenses = ($14,060,197) Rescinded Grants = $1,734,535 ----------- Total ($2,655,900)